Towa Pharmaceutical Co Ltd
TSE:4553
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Towa Pharmaceutical Co Ltd
TSE:4553
|
JP |
|
ZOA Corp
TSE:3375
|
JP |
|
C
|
Changhae Ethanol Co Ltd
KOSDAQ:004650
|
KR |
|
C
|
CFECapital S de RL de CV
BMV:FCFE18
|
MX |
|
C
|
Carasso Real Estate Ltd
TASE:CRSR
|
IL |
|
G
|
Genexine Inc
KOSDAQ:095700
|
KR |
|
Pipestone Energy Corp
TSX:PIPE
|
CA |
|
G
|
Greattown Holdings Ltd
SSE:600094
|
CN |
|
C
|
Cosigo Resources Ltd
OTC:COSRF
|
CA |
|
H
|
Health Advance Inc
OTC:HADV
|
US |
|
BOC Hong Kong Holdings Ltd
HKEX:2388
|
HK |
|
S
|
Sarawak Plantation Bhd
KLSE:SWKPLNT
|
MY |
|
Powermatic Data Systems Ltd
SGX:BCY
|
SG |
Wall Street
Price Targets
Price Targets Summary
Towa Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for
Towa Pharmaceutical Co Ltd
is 4 773.6 JPY
with a low forecast of 3 939 JPY and a high forecast of 5 670 JPY.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Towa Pharmaceutical Co Ltd's stock price target?
Price Target
4 773.6
JPY
According to Wall Street analysts, the average 1-year price target for
Towa Pharmaceutical Co Ltd
is 4 773.6 JPY
with a low forecast of 3 939 JPY and a high forecast of 5 670 JPY.
What is Towa Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
6%
For the last 13 years the
compound annual growth rate for
Towa Pharmaceutical Co Ltd's revenue is
14%.
The projected
CAGR
for the next 3 years is
6%.
What is Towa Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
-7%
For the last 13 years the
compound annual growth rate for
Towa Pharmaceutical Co Ltd's operating income is
7%.
The projected
CAGR
for the next 13 years is
-7%.
What is Towa Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
6%
For the last 13 years the
compound annual growth rate for
Towa Pharmaceutical Co Ltd's net income is
10%.
The projected
CAGR
for the next 3 years is
6%.
